The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Sk Biopharmaceuticals competitive analysis

Loading summary...

Latest patents of Sk Biopharmaceuticals opposed by its competitors

Explore Sk Biopharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3711758
Mar 27, 2024Use Of Carbamate Compound For Preventing, Alleviating Or Treating Absence Seizure Or Epilepsy Showing Absence Seizure3
EP3509582
Dec 20, 2023Solvate Form Of (R)-2-Amino-3-Phenylpropyl Carbamate1
EP2968208
Jul 20, 2022Treatment Of Cataplexy1

Latest PTAB cases involving Sk Biopharmaceuticals

Discover the latest PTAB cases involving Sk Biopharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sk Biopharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SK BIOPHARMACEUTICALS - 5 - -
DENNEMEYER & ASSOCIATES3 - - -
HAMM & WITTKOPP112 - - -
KRAUS & LEDERER PARTGMBB68 - - -